MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc.（MAIA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · MAIA · 截至 2026年6月9日
活动摘要
买入笔数
32
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
MAIA Biotechnology, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
MAIA 季度内部人买卖趋势
MAIA 内幕交易卖出 · MAIA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · MAIA CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
MAIA 高管卖出股份 · MAIA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 1, 2026 | Vitoc Vlad CEO · Director | Purchase | 72,700 | $101K | Form 4 |
| Jun 1, 2026 | Smith Stan Director | Purchase | 75,000 | $100K | Form 4 |
| Jun 1, 2026 | Gryaznov Sergei Chief Scientific Officer | Purchase | 2,000 | $3K | Form 4 |
| May 1, 2024 | Smith Stan Director | Gift | 20,000 | — | Form 4 |
| Sep 19, 2022 | Smith Stan Director | Purchase | 2,700 | $10K | Form 4 |
| Dec 22, 2025 | Smith Stan Director | Purchase | 57,189 | $70K | Form 4 |
| Dec 22, 2025 | CHAOUKI STEVEN M Director | Purchase | 40,849 | $50K | Form 4 |
| Dec 22, 2025 | Louie Ngar Yee Director | Purchase | 81,699 | $100K | Form 4 |
| Dec 5, 2025 | Smith Stan Director | Purchase | 4,580 | $5K | Form 4 |
| Dec 5, 2025 | Smith Stan Director | Purchase | 4,580 | $5K | Form 4 |
| Dec 5, 2025 | Smith Stan Director | Purchase | 4,580 | $5K | Form 4 |
| Nov 28, 2025 | Vitoc Vlad CEO · Director | Purchase | 50,000 | $57K | Form 4 |
| Nov 26, 2025 | Vitoc Vlad CEO · Director | Purchase | 22,000 | $23K | Form 4 |
| Nov 28, 2025 | Luput Cristian Director | Purchase | 18,145 | $20K | Form 4 |
| Nov 26, 2025 | Luput Cristian Director | Purchase | 20,000 | $22K | Form 4 |
| Nov 26, 2025 | Smith Stan Director | Purchase | 15,000 | $16K | Form 4 |
| Nov 25, 2025 | Luput Cristian Director | Purchase | 10,000 | $10K | Form 4 |
| Nov 25, 2025 | Vitoc Vlad CEO · Director | Purchase | 10,500 | $10K | Form 4 |
| Nov 25, 2025 | Smith Stan Director | Purchase | 15,000 | $15K | Form 4 |
| Nov 24, 2025 | Smith Stan Director | Purchase | 10,000 | $10K | Form 4 |
| Nov 24, 2025 | Vitoc Vlad CEO · Director | Purchase | 10,000 | $10K | Form 4 |
| Nov 21, 2025 | Vitoc Vlad CEO · Director | Purchase | 1,800 | $2K | Form 4 |
| Oct 1, 2025 | Smith Stan Director | Purchase | 19,230 | $25K | Form 4 |
| Jun 3, 2025 | Smith Stan Director | Purchase | 33,333 | $50K | Form 4 |
| May 8, 2025 | Guerrero Ramiro Director | Purchase | 20,000 | $30K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 MAIA 内幕交易
MAIA 内幕交易
MAIA Biotechnology, Inc.（MAIA）内幕交易数据来源于公司内部人（包括Smith Stan (Director), Vitoc Vlad (CEO · Director), Luput Cristian (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。MAIA内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看MAIA Biotechnology, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
MAIA 内幕交易 · 5个问题MAIA Biotechnology, Inc.（MAIA）的内部人包括高管和董事，如Smith Stan (Director), Vitoc Vlad (CEO · Director), Luput Cristian (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026